TFF1 knockdown enhanced anchorage-independent growth in breast cancer cells in vivo and in vitro [52], reduced apoptosis and induced proliferation in gastric cancer cells [53], and accelerated the development of esophageal adenocarcinoma [54] and hepatocellular carcinoma in vivo [51]. The gene discussed is TFF1; the disease is esophageal adenocarcinoma.